CN105412210A - Health-care food composition - Google Patents
Health-care food composition Download PDFInfo
- Publication number
- CN105412210A CN105412210A CN201510911746.2A CN201510911746A CN105412210A CN 105412210 A CN105412210 A CN 105412210A CN 201510911746 A CN201510911746 A CN 201510911746A CN 105412210 A CN105412210 A CN 105412210A
- Authority
- CN
- China
- Prior art keywords
- health
- extract
- food composition
- care food
- radix astragali
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 39
- 235000013305 food Nutrition 0.000 title claims abstract description 26
- 239000000284 extract Substances 0.000 claims abstract description 58
- 241000222336 Ganoderma Species 0.000 claims abstract description 33
- 239000009636 Huang Qi Substances 0.000 claims description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 25
- 238000002360 preparation method Methods 0.000 claims description 13
- 206010013786 Dry skin Diseases 0.000 claims description 8
- 238000001035 drying Methods 0.000 claims description 8
- 239000000706 filtrate Substances 0.000 claims description 8
- -1 soak 2 hours Substances 0.000 claims description 8
- 239000002994 raw material Substances 0.000 claims description 6
- 208000033065 inborn errors of immunity Diseases 0.000 claims description 4
- 208000028529 primary immunodeficiency disease Diseases 0.000 claims description 4
- 235000013402 health food Nutrition 0.000 claims description 2
- 239000007787 solid Substances 0.000 claims description 2
- 230000036737 immune function Effects 0.000 abstract description 3
- 238000011160 research Methods 0.000 abstract description 3
- 235000019206 astragalus extract Nutrition 0.000 abstract 2
- 238000010339 medical test Methods 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 44
- 239000002904 solvent Substances 0.000 description 21
- 230000000242 pagocytic effect Effects 0.000 description 16
- 230000036039 immunity Effects 0.000 description 9
- 239000008187 granular material Substances 0.000 description 7
- 239000002775 capsule Substances 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 239000004375 Dextrin Substances 0.000 description 5
- 229920001353 Dextrin Polymers 0.000 description 5
- 241000287828 Gallus gallus Species 0.000 description 5
- 241000699670 Mus sp. Species 0.000 description 5
- 235000019425 dextrin Nutrition 0.000 description 5
- 210000003743 erythrocyte Anatomy 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 206010018910 Haemolysis Diseases 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 230000008588 hemolysis Effects 0.000 description 4
- 241000699666 Mus <mouse, genus> Species 0.000 description 3
- 241000700605 Viruses Species 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 238000003304 gavage Methods 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 210000003024 peritoneal macrophage Anatomy 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 230000007306 turnover Effects 0.000 description 3
- 230000004584 weight gain Effects 0.000 description 3
- 235000019786 weight gain Nutrition 0.000 description 3
- 206010057249 Phagocytosis Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000003228 hemolysin Substances 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 230000008782 phagocytosis Effects 0.000 description 2
- 238000004393 prognosis Methods 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 241000233866 Fungi Species 0.000 description 1
- 108010006464 Hemolysin Proteins Proteins 0.000 description 1
- 206010024264 Lethargy Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 206010016256 fatigue Diseases 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 208000019116 sleep disease Diseases 0.000 description 1
- 208000020685 sleep-wake disease Diseases 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of health-care food, and particularly relates to a health-care food composition. The health-care food composition is characterized by being prepared from an astragalus extract and a ganoderma extract. Through years of clinical research, by combining modern medical tests, the astragalus extract is greatly used in the formula and cooperates with ganoderma to be used for treating a Qi-deficiency patient who is low in immune function.
Description
Technical field
The present invention relates to technical field of health care food, be specifically related to a kind of health-care food composition.
Background technology
Body immunity is the ability that people resist environment and virus.Our health is all faced with the invasion and attack of antibacterial, virus all the time, normal immunocompetence can help us to resist the invasion and attack of exotic, body is made to be in the state of a relatively stable and dynamic equilibrium, ensure that the vis medicatrix naturae of health is played, thus make our health can from the hardship of disease.
Hypoimmunity is a kind of form of expression that immunologic function suffers damage, and the crowd of hypoimmunity is easily infected, and very easily cause the infection such as antibacterial, virus, fungus, it the most directly shows as liable to illness.Also can with performances such as lethargy, fatigue and weak, loss of appetite, sleep disorder.
The immunity that modern medicine is thought said to the traditional Chinese medical science " healthy energy " is similar, the living matter of general reference human normal and functional activity thereof.Chinese medicine is thought " healthy energy deposit in, heresy can not be done "; " gathering of heresy, its gas must be empty ".Healthy energy be the evil sequela of human body sense whether, the key of prognosis of disease, prognosis quality.Therefore, the traditional Chinese medical science, mainly through QI invigorating and body resistance strengthening, makes QI and blood keep normal physiological function, and make body keep QI and blood gentle, the steady statue of YIN and YANG in a relative equilibrium, to reach the effect of enhancing human body immunity.
Summary of the invention
For these reasons, applicant, through clinical research for many years, in conjunction with modern medicine test, reuses Radix Astragali extract, is aided with Ganoderma, thus be used for the treatment of the patient that immunologic hypofunction belongs to the deficiency of vital energy in prescription.
The present invention is directed to immunologic hypofunction belong to the crowd of the deficiency of vital energy and establish, the choose reasonable Radix Astragali, Ganoderma compatibility, the Radix Astragali is sweet, tepor, returns lung, spleen channel, and Ganoderma is sweet, flat, and GUIXIN, lung, liver, kidney channel, have the merit of QI invigorating and body resistance strengthening.Both share, and play the merit that QI invigorating and body resistance strengthening consolidates altogether, and do not have incompatibility.Meanwhile, in conjunction with modern medicine and threpsology to the achievement in research improving immunity of organisms, composition has the compositions of enhancing immunity health care.
One object of the present invention is open a kind of health-care food composition; Another object of the present invention is openly a kind of health-care food composition with enhancing immunity function; The present invention also aims to the preparation method disclosing this health-care food composition.
The present invention seeks to be achieved through the following technical solutions:
1, a health-care food composition, is characterized in that compositions is made up of following raw material: Radix Astragali extract and Ganoderma extract.
2, a kind of health-care food composition according to claim 1, wherein Radix Astragali extract 15 ~ 60 weight portion, Ganoderma extract 1 ~ 10 weight portion.
3, a kind of health-care food composition according to claim 1, wherein Radix Astragali extract 20 ~ 45 weight portion, Ganoderma extract 3 ~ 6 weight portion.
4, a kind of health-care food composition according to claim 1, wherein Radix Astragali extract 30 weight portion, Ganoderma extract 4.1 weight portion.
5, a kind of health-care food composition according to any one of claim 1-4, wherein the preparation method of Radix Astragali extract is: get the Radix Astragali and add water, soak 2 hours, extract 2 times, each 2 hours, first time adds 10 times of water gagings, second time adds 8 times of water gagings, filters, filtrate reduced in volume to 60 DEG C relative density 1.25-1.30,60 DEG C of-70 DEG C of dryings, obtain Radix Astragali extract;
Wherein the preparation method of Ganoderma extract is: get Ganoderma and add water, and soaks 2 hours, extracts 2 times, each 2 hours, first time adds 10 times of water gagings, and second time adds 8 times of water gagings, filters, filtrate reduced in volume to 60 DEG C relative density 1.25-1.30,60 DEG C of-70 DEG C of dryings, obtain Ganoderma extract.
6, a kind of health-care food composition according to any one of claim 1-4, is characterized in that health-care food composition is prepared into solid preparation.
7, a kind of health-care food composition according to any one of claim 1-4 is preparing the application treated and/or prevented in the health food of hypoimmunity.
Detailed description of the invention
Enhancing immunity functional trial:
Laboratory animal: the SPF level 18-22g male mice in kunming selecting the breeding of the long-living biological company limited in Liaoning.
Test grouping:
Test 1 group: Radix Astragali extract 30g, Ganoderma extract 4.1g;
Test 2 groups: Radix Astragali extract 18g, Ganoderma extract 7g;
Test 3 groups: Radix Astragali extract 5g, Ganoderma extract 25g.
Wherein testing 1 group is the combination of present composition optimal proportion; Within the scope of the proportioning raw materials that the proportioning raw materials testing 2 groups is protected at the present composition; Outside the proportioning raw materials scope that the proportioning raw materials testing 3 groups is protected at the present composition.
The preparation method of Radix Astragali extract is: get the Radix Astragali and add water, and soaks 2 hours, extracts 2 times, each 2 hours, first time adds 10 times of water gagings, and second time adds 8 times of water gagings, filters, filtrate reduced in volume to 60 DEG C relative density 1.25-1.30,60 DEG C of-70 DEG C of dryings, obtain Radix Astragali extract;
Wherein the preparation method of Ganoderma extract is: get Ganoderma and add water, and soaks 2 hours, extracts 2 times, each 2 hours, first time adds 10 times of water gagings, and second time adds 8 times of water gagings, filters, filtrate reduced in volume to 60 DEG C relative density 1.25-1.30,60 DEG C of-70 DEG C of dryings, obtain Ganoderma extract.
Metering is selected and tested material gives mode: by 30 times (1.20g/kgBW) design recommending human body daily intaking amount, test is established test 1 group, tests 2 groups, tested 3 groups of three groups and sample solvent matched group.Take tested material 6.00g respectively, add distilled water and be adjusted to 100mL, sample preparation concentration is 6.00g/mL, Fresh during use.Gavage mode gives sample, by body weight adjustment gavage capacity, every day gavage 1 time, continuous 30 days.Last measures every immune indexes respectively to after sample 30min.
1, antibody-producting cell detects and mice serum hemolysin test result of the test:
Each test group original body mass, test opisthosoma are heavy, weight gain compares with sample solvent matched group, there was no significant difference (P>0.05); Test 1 group, test the hemolysis plaque number of 2 groups and be significantly higher than sample solvent matched group (P<0.05); Test 1 group, test the antibody product of 2 groups and be significantly higher than sample solvent matched group (P<0.05); Test the hemolysis plaque number of 3 groups, antibody product and solvent control group there was no significant difference (P>0.05).
Body weight measurements (the unit: g) that table 1 antibody-producting cell detects and serum hemolysin measures
Table 2 antibody-producting cell detects plaque number and serolysin test antibody product measurement result
2, mice carbonic clearance result of the test:
Each experimental group original body mass, test opisthosoma are heavy, weight gain compares with sample solvent matched group, there was no significant difference (P>0.05); The phagocytic index a testing 1 group is significantly higher than sample solvent matched group (P<0.05).
Table 3 mice carbonic clearance test body weight measurements (unit: g)
Table 4 mice carbonic clearance test phagocytic index a measurement result
3, Turnover of Mouse Peritoneal Macrophages engulfs chicken red blood cell result of the test:
Each experimental group original body mass, test opisthosoma are heavy, weight gain compares with sample solvent matched group, there was no significant difference (P>0.05); Test the phagocytic percentage of 1 group, phagocytic index is significantly higher than solvent control group (P<0.01); Test the phagocytic percentage of 2 groups, phagocytic index is significantly higher than solvent control group (P<0.05); Test 3 groups and solvent control group there was no significant difference (P>0.05).
Table 5 Turnover of Mouse Peritoneal Macrophages engulfs chicken red blood cell test body weight measurements (unit: g)
Table 6 Turnover of Mouse Peritoneal Macrophages engulfs chicken red blood cell test phagocytic percentage, phagocytic index measurement result
Result judges: in the immunologic function test carry out three groups of tested materials and one group of solvent control, the hemolysis plaque number testing 1 group is significantly higher than sample solvent matched group (P<0.05); Antibody product is significantly higher than sample solvent matched group (P<0.05); Carbonic clearance phagocytosis test phagocytic index a is significantly higher than sample solvent matched group (P<0.05); Macrophage phagocytic chicken red blood cell phagocytic percentage, phagocytic index are significantly higher than solvent control group (P<0.01).
The hemolysis plaque number testing 2 groups is significantly higher than sample solvent matched group (P<0.05); Antibody product is significantly higher than sample solvent matched group (P<0.05); Carbonic clearance phagocytosis test phagocytic index a and sample solvent matched group there was no significant difference (P>0.05); Macrophage phagocytic chicken red blood cell phagocytic percentage, phagocytic index are significantly higher than solvent control group (P<0.05).
Test the above-mentioned result of the test of 3 groups there are no significant compared with sample solvent matched group difference (P>0.05).Known, test 1 group, test 2 groups there is enhancing immunity function, and test 1 group is more better than test 2 groups; Test 3 groups and not there is enhancing immunity function.
Preparation embodiment:
Embodiment 1: get 30kg Radix Astragali extract, 4.17kg Ganoderma extract, add 5.43kg dextrin, mix homogeneously, granulates, adds 0.4kg magnesium stearate, mix homogeneously, loads capsule, obtains capsule.
Embodiment 2: get 25kg Radix Astragali extract, 9kg Ganoderma extract, add 5.6kg dextrin, mix homogeneously, granulates, adds 0.4kg magnesium stearate, mix homogeneously, loads capsule, obtains capsule.
Embodiment 3: get 35kg Radix Astragali extract, 2kg Ganoderma extract, add 2.5kg dextrin, mix homogeneously, granulates, adds 0.5kg magnesium stearate, mix homogeneously, loads capsule, obtains capsule.
Embodiment 4: get 30kg Radix Astragali extract, 4.17kg Ganoderma extract, adds 2.43kg dextrin, 3kg starch, 0.4kg microcrystalline Cellulose, mix homogeneously, and granulate, granulate, tabletting, obtains tablet.
Embodiment 5: get 30kg Radix Astragali extract, 4kg Ganoderma extract, adds 50kg dextrin, 15kg Icing Sugar, mix homogeneously, granulates, obtains granule.
The preparation method of Radix Astragali extract described above is: get the Radix Astragali and add water, and soaks 2 hours, extracts 2 times, each 2 hours, first time adds 10 times of water gagings, and second time adds 8 times of water gagings, filters, filtrate reduced in volume to 60 DEG C relative density 1.25-1.30,60 DEG C of-70 DEG C of dryings, obtain Radix Astragali extract;
The preparation method of wherein Ganoderma extract described above is: get Ganoderma and add water, soak 2 hours, extract 2 times, each 2 hours, first time added 10 times of water gagings, and second time adds 8 times of water gagings, filter, filtrate reduced in volume to 60 DEG C relative density 1.25-1.30,60 DEG C of-70 DEG C of dryings, obtain Ganoderma extract.
Claims (7)
1. a health-care food composition, is characterized in that compositions is made up of following raw material: Radix Astragali extract and Ganoderma extract.
2. a kind of health-care food composition according to claim 1, wherein Radix Astragali extract 15 ~ 60 weight portion, Ganoderma extract 1 ~ 10 weight portion.
3. a kind of health-care food composition according to claim 1, wherein Radix Astragali extract 20 ~ 45 weight portion, Ganoderma extract 3 ~ 6 weight portion.
4. a kind of health-care food composition according to claim 1, wherein Radix Astragali extract 30 weight portion, Ganoderma extract 4.1 weight portion.
5. a kind of health-care food composition according to any one of claim 1-4, wherein the preparation method of Radix Astragali extract is: get the Radix Astragali and add water, soak 2 hours, extract 2 times, each 2 hours, first time adds 10 times of water gagings, second time adds 8 times of water gagings, filters, filtrate reduced in volume to 60 DEG C relative density 1.25-1.30,60 DEG C of-70 DEG C of dryings, obtain Radix Astragali extract;
Wherein the preparation method of Ganoderma extract is: get Ganoderma and add water, and soaks 2 hours, extracts 2 times, each 2 hours, first time adds 10 times of water gagings, and second time adds 8 times of water gagings, filters, filtrate reduced in volume to 60 DEG C relative density 1.25-1.30,60 DEG C of-70 DEG C of dryings, obtain Ganoderma extract.
6. a kind of health-care food composition according to any one of claim 1-4, is characterized in that health-care food composition is prepared into solid preparation.
7. a kind of health-care food composition according to any one of claim 1-4 is preparing the application treated and/or prevented in the health food of hypoimmunity.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510911746.2A CN105412210A (en) | 2015-12-11 | 2015-12-11 | Health-care food composition |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510911746.2A CN105412210A (en) | 2015-12-11 | 2015-12-11 | Health-care food composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105412210A true CN105412210A (en) | 2016-03-23 |
Family
ID=55491059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510911746.2A Pending CN105412210A (en) | 2015-12-11 | 2015-12-11 | Health-care food composition |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105412210A (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104815050A (en) * | 2015-05-20 | 2015-08-05 | 吉林大学 | Slimming and fat-burning assistant health food and preparation method thereof |
| CN105999096A (en) * | 2016-07-07 | 2016-10-12 | 天津天狮生物发展有限公司 | Composition for enhancing immunity and application |
| WO2019024014A1 (en) * | 2017-08-02 | 2019-02-07 | 江苏安惠生物科技有限公司 | Health-care capsule for enhancing immunity and relieving fatigue |
| CN109793811A (en) * | 2019-03-26 | 2019-05-24 | 上海市农业科学院 | A kind of Lingzhu ' that triple function being immunized with inhibition hyperplasia of prostate, liver protection, raising |
| CN111905092A (en) * | 2020-09-23 | 2020-11-10 | 桂明霞 | Traditional Chinese medicine preparation for removing dampness, expelling toxin and tonifying qi as well as preparation method and application thereof |
| CN113069484A (en) * | 2021-03-12 | 2021-07-06 | 黑龙江中医药大学 | Anti-aging medicine and preparation method of microcapsule preparation thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1586300A (en) * | 2004-06-28 | 2005-03-02 | 陈萍 | Method for preparing health food for improving immunological function |
| CN101780136A (en) * | 2010-03-17 | 2010-07-21 | 上海大学 | Medicine and food dual-purpose traditional Chinese medicine composition with anti-tumor activity and immunoregulation effect and application thereof |
| CN101810337A (en) * | 2010-05-11 | 2010-08-25 | 苏豹 | Health food containing pseudo-ginseng and ganoderma lucidum and radix astragali |
| CN103039955A (en) * | 2012-12-28 | 2013-04-17 | 杨石 | Health food with function of boosting immunity |
| CN103202479A (en) * | 2013-05-03 | 2013-07-17 | 高益槐 | Health protection food for adjusting immunity function and preparation method thereof |
-
2015
- 2015-12-11 CN CN201510911746.2A patent/CN105412210A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1586300A (en) * | 2004-06-28 | 2005-03-02 | 陈萍 | Method for preparing health food for improving immunological function |
| CN101780136A (en) * | 2010-03-17 | 2010-07-21 | 上海大学 | Medicine and food dual-purpose traditional Chinese medicine composition with anti-tumor activity and immunoregulation effect and application thereof |
| CN101810337A (en) * | 2010-05-11 | 2010-08-25 | 苏豹 | Health food containing pseudo-ginseng and ganoderma lucidum and radix astragali |
| CN103039955A (en) * | 2012-12-28 | 2013-04-17 | 杨石 | Health food with function of boosting immunity |
| CN103202479A (en) * | 2013-05-03 | 2013-07-17 | 高益槐 | Health protection food for adjusting immunity function and preparation method thereof |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN104815050A (en) * | 2015-05-20 | 2015-08-05 | 吉林大学 | Slimming and fat-burning assistant health food and preparation method thereof |
| CN104815050B (en) * | 2015-05-20 | 2018-06-08 | 吉林大学 | It is a kind of that thin body is assisted to disappear the health food and preparation method thereof of fat |
| CN105999096A (en) * | 2016-07-07 | 2016-10-12 | 天津天狮生物发展有限公司 | Composition for enhancing immunity and application |
| WO2019024014A1 (en) * | 2017-08-02 | 2019-02-07 | 江苏安惠生物科技有限公司 | Health-care capsule for enhancing immunity and relieving fatigue |
| CN109793811A (en) * | 2019-03-26 | 2019-05-24 | 上海市农业科学院 | A kind of Lingzhu ' that triple function being immunized with inhibition hyperplasia of prostate, liver protection, raising |
| CN111905092A (en) * | 2020-09-23 | 2020-11-10 | 桂明霞 | Traditional Chinese medicine preparation for removing dampness, expelling toxin and tonifying qi as well as preparation method and application thereof |
| CN113069484A (en) * | 2021-03-12 | 2021-07-06 | 黑龙江中医药大学 | Anti-aging medicine and preparation method of microcapsule preparation thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN105412210A (en) | Health-care food composition | |
| CN103735825B (en) | Comprehensively regulating Chinese medicine composition and application thereof | |
| CN102600212B (en) | Medicinal health product for immunity enhancement and adjuvant treatment of tumor | |
| CN105816623A (en) | Probiotic fermented traditional Chinese medicinal compound composition for treating and improving metabolic syndrome, and preparation method and application thereof | |
| CN101869656B (en) | Chinese medicinal preparation for treating cough with asthma and preparation method thereof | |
| CN105748622A (en) | Probiotic fermented traditional Chinese medicine composition for spasmolysis and analgesia and preparation method and application thereof | |
| CN103169737B (en) | Composite of Antrodia camphorata entity and shell-broken ganoderma lucidum spore powder and application thereof in immune adjustment | |
| CN102551058A (en) | Chinese medicinal health-care product with function of enhancing immunity | |
| CN100574768C (en) | A kind of anticancer pharmaceutical composition and its production and use | |
| CN1772189B (en) | Auxiliary treating medicine for lung cancer in late stage | |
| CN109394809A (en) | A kind of Chinese medicine composition and its preparation method and application improving immunity | |
| CN103755827B (en) | The purposes of Lachnum exocellular polysaccharide carboxyl methylation derivant and renal failure resistant medicine processed thereof | |
| CN108743796B (en) | Traditional Chinese medicine composition for treating lung cancer and application thereof | |
| CN102935111B (en) | Traditional Chinese medicinal composition for enhancing human body immunity and technology for preparing traditional Chinese medicinal composition | |
| CN105749154A (en) | Probiotic fermented traditional Chinese medicine compound composition for treating liver cancer and preparation and detection methods thereof | |
| CN110464801A (en) | A kind of Chinese medicine composition and its preparation method and application for treating advanced breast cancer | |
| CN106491834A (en) | A kind of veterinary Chinese medicinal composition and its preparation method and application of granule | |
| CN103735621B (en) | A kind of Chinese medicine composition with blood fat reducing and enhancing immunity effect | |
| CN108498743A (en) | A kind of prescription for treating Chronic Obstructive Pulmonary Disease syndrome of deficiency of lung qi | |
| CN102652774B (en) | Drug composition for treating leukopenia and hypoimmunity caused by chemoradiotherapy and preparation method and quality detection method | |
| CN1911329B (en) | Traditional Chinese medicine composition for preventing and/or adjuvant therapy of malignant tumor | |
| CN106177014A (en) | A kind of Cordyceps militaris (L.) Link. granule of enhancing immunity and preparation method thereof | |
| CN102697800B (en) | Herba stellariae mediae polysaccharide composition and the application in preparation antiviral drugs thereof | |
| CN100546621C (en) | A kind of new purposes of known drug | |
| CN102872374B (en) | Chinese medicinal composition for assisting tumor radiotherapy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160323 |
|
| WD01 | Invention patent application deemed withdrawn after publication |